REGENERON PHARMACEUTICALS, INC. - 8-K Filing
Regeneron and Sanofi expand collaboration with $1B upfront payment for four new antibodies (Items: 2.02 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall such information be deem)
Tickers: $REGN